Sitemap
February 26, 2008 Articles
Filter by Available Specialty
- AMO licenses microprocessor technology in United States, abroad
- Bevacizumab plus paclitaxel granted accelerated approval for breast cancer
- Inspire reports $63.7 million net loss, 31% total revenue increase for 2007
- Interpositional arthroplasty using a dermal tissue spacer shows efficacy for treating hallux rigidus
- Novel method of compounding preservative-free triamcinolone simple, reproducible
- Sirion, Bridge Pharma enter license agreement for potential ocular anti-inflammatory drug